US146439A
(en)
*
|
|
1874-01-13 |
|
Improvement in pruning-shears |
US37914A
(en)
*
|
|
1863-03-17 |
|
Improved automatic nose-bag |
US37913A
(en)
*
|
|
1863-03-17 |
|
Improvement in sewing-machines |
DE1617477U
(de)
|
1950-09-27 |
1950-12-14 |
Heinrich Dressel |
Radhalter fuer raeder, beispielsweise fuer kinderwagen und kleinfahrzeuge.
|
US3776938A
(en)
*
|
1958-05-28 |
1973-12-04 |
S Bergstrom |
Dihydro-pge1
|
US3839409A
(en)
*
|
1958-05-28 |
1974-10-01 |
Kemiska Inst Karolinska I |
Pge3 esters and alkanoates
|
US3069322A
(en)
*
|
1958-05-28 |
1962-12-18 |
Bergstrom Sune |
Pge and pgf
|
US3776939A
(en)
*
|
1958-05-28 |
1973-12-04 |
S Bergstrom |
Dihydro-pgf1a
|
US3382247A
(en)
*
|
1965-11-01 |
1968-05-07 |
Upjohn Co |
6-amino-1, 2-dihydro-1-hydroxy-2-imino-4-phenoxypyrimidines
|
US3435053A
(en)
*
|
1966-06-06 |
1969-03-25 |
Upjohn Co |
Cyclopenta(b)pyrans
|
US3524867A
(en)
*
|
1966-06-06 |
1970-08-18 |
Upjohn Co |
Process for producing cyclopenta (b)pyrans
|
US3538120A
(en)
|
1967-05-22 |
1970-11-03 |
Ciba Geigy Corp |
Cyclopentyl-alkanoic acids
|
DE1617477A1
(de)
|
1967-06-22 |
1970-01-08 |
Fischer Geb Beutelschiess Alwi |
Biologisches Haarwuchs-Tonicum mit Garantie
|
US3636120A
(en)
*
|
1967-10-09 |
1972-01-18 |
Upjohn Co |
Prostaglandin e primary alcohols
|
GB1285372A
(en)
|
1968-08-29 |
1972-08-16 |
Upjohn Co |
Improvements in or relating to prostaglandins and the preparation thereof
|
GB1251750A
(de)
|
1968-11-12 |
1971-10-27 |
|
|
DE1910561A1
(de)
|
1969-03-01 |
1970-09-10 |
Herten Dr Med Kurt |
Mittel zur Verhuetung von Haarausfall
|
BE755555A
(fr)
*
|
1969-09-02 |
1971-03-01 |
Richardson Merrell Inc |
Derives de quinoxaline
|
US3882241A
(en)
*
|
1969-12-01 |
1975-05-06 |
Upjohn Co |
Use of prostaglandins E and F for prevention of pregnancy in humans
|
US3896156A
(en)
*
|
1970-06-30 |
1975-07-22 |
Upjohn Co |
Dihydroprostaglandin e, analogs
|
IT1012505B
(it)
|
1970-09-28 |
1977-03-10 |
Imes C Spa |
Estratto di ricci di mare
|
GB1324737A
(en)
|
1970-11-02 |
1973-07-25 |
Upjohn Co |
Prostaglandins and the preparation thereof
|
JPS5212919Y2
(de)
|
1971-06-14 |
1977-03-23 |
|
|
BE791369A
(fr)
|
1971-11-16 |
1973-05-14 |
American Cyanamid Co |
Cyanurates de tris-(meta-hydroxybenzyle) faisant l'objet d'un empechement sterique et utilisables comme anti-oxydants
|
JPS525744Y2
(de)
|
1972-03-18 |
1977-02-05 |
|
|
US3798275A
(en)
*
|
1972-04-05 |
1974-03-19 |
Ciba Geigy Corp |
Etherified mercapto-methoxyamines
|
GB1386146A
(en)
|
1972-05-03 |
1975-03-05 |
Ici Ltd |
Cyclopentane derivatives
|
US4304907A
(en)
|
1972-05-10 |
1981-12-08 |
The Upjohn Company |
Bicyclo lactone intermediates for prostaglandin analogs
|
US3974213A
(en)
|
1972-07-13 |
1976-08-10 |
Pfizer Inc. |
13,14-Dihydro-15-substituted-ω-pentanorprostaglandins
|
US4011262A
(en)
*
|
1972-07-13 |
1977-03-08 |
Pfizer Inc. |
13,14-Dihydro-15-substituted-ω-pentanorprostaglandins of the two series
|
GB1428137A
(en)
|
1972-09-27 |
1976-03-17 |
Ici Ltd |
Prostanoic acid derivatives
|
JPS4969636U
(de)
|
1972-09-29 |
1974-06-18 |
|
|
JPS5220141Y2
(de)
|
1972-10-13 |
1977-05-10 |
|
|
US3882245A
(en)
*
|
1972-11-01 |
1975-05-06 |
Upjohn Co |
Use of prostaglandins in combating shock
|
JPS4969636A
(de)
|
1972-11-07 |
1974-07-05 |
|
|
US4024179A
(en)
*
|
1972-11-08 |
1977-05-17 |
Pfizer Inc. |
Substituted ω-pentanorprostaglandins
|
IL50310A
(en)
|
1972-11-08 |
1977-08-31 |
Pfizer |
Dimethyl ketophosphonates
|
DD118856A5
(de)
|
1972-11-08 |
1976-03-20 |
|
|
US3984424A
(en)
|
1972-11-08 |
1976-10-05 |
Pfizer Inc. |
P-biphenyl esters of 15-substituted-ω-pentanorprostaglandins
|
US4152527A
(en)
*
|
1972-11-08 |
1979-05-01 |
Pfizer Inc. |
15-Substituted-ω-pentanorprostaglandins
|
JPS4993342U
(de)
|
1972-12-05 |
1974-08-13 |
|
|
JPS5253841Y2
(de)
|
1972-12-12 |
1977-12-07 |
|
|
JPS49100071U
(de)
|
1972-12-20 |
1974-08-28 |
|
|
JPS49101356U
(de)
|
1972-12-20 |
1974-08-31 |
|
|
JPS5320995Y2
(de)
|
1972-12-23 |
1978-06-02 |
|
|
JPS49101356A
(de)
|
1973-02-07 |
1974-09-25 |
|
|
JPS49102647A
(de)
|
1973-02-14 |
1974-09-27 |
|
|
JPS5720305B2
(de)
*
|
1973-02-28 |
1982-04-27 |
|
|
US3984455A
(en)
*
|
1973-07-16 |
1976-10-05 |
The Upjohn Company |
Prostaglandin E1 analogs
|
JPS5118118Y2
(de)
|
1973-07-17 |
1976-05-14 |
|
|
FR2239458A1
(en)
|
1973-07-31 |
1975-02-28 |
Aries Robert |
Prostaglandin amides - with antilipolytic, gonadotrophic, luteolytic, hypotensive and other activities associated with prostaglandins
|
DE2365101A1
(de)
*
|
1973-12-21 |
1975-07-10 |
Schering Ag |
Neue prostansaeurederivate und verfahren zu ihrer herstellung
|
US3931282A
(en)
|
1974-02-21 |
1976-01-06 |
Syntex (U.S.A.) Inc. |
11α-Hydroxymethyl prostaglandins
|
US3928588A
(en)
*
|
1974-02-22 |
1975-12-23 |
Upjohn Co |
Method of reducing the undesirable gastrointestinal effects of prostaglandin synthetase inhibitors
|
JPS50157344A
(de)
|
1974-03-20 |
1975-12-19 |
|
|
DE2416193C2
(de)
*
|
1974-04-03 |
1985-08-14 |
Hoechst Ag, 6230 Frankfurt |
Prostaglandin-Analoge, Verfahren zu ihrer Herstellung sowie ihre Verwendung als cytoprotektives Mittel
|
GB1458315A
(en)
|
1974-04-22 |
1976-12-15 |
Ici Ltd |
Prostanoic acid derivatives
|
JPS50142539U
(de)
|
1974-05-13 |
1975-11-25 |
|
|
JPS50157344U
(de)
|
1974-06-12 |
1975-12-26 |
|
|
US3964455A
(en)
*
|
1974-12-19 |
1976-06-22 |
General Motors Corporation |
Valve control mechanism
|
DE2460990A1
(de)
|
1974-12-21 |
1976-07-01 |
Hoechst Ag |
Neue prostaglandin-analoga und verfahren zu ihrer herstellung
|
JPS5186449U
(de)
|
1974-12-30 |
1976-07-10 |
|
|
GB1507211A
(en)
*
|
1975-02-14 |
1978-04-12 |
Ono Pharmaceutical Co |
Prostaglandin analogues
|
US3934013A
(en)
|
1975-02-21 |
1976-01-20 |
Syntex (U.S.A.) Inc. |
Pharmaceutical composition
|
US4217360A
(en)
*
|
1975-02-27 |
1980-08-12 |
Schering Aktiengesellschaft |
Novel 1,3-benzodioxaneprostanoic acid derivatives and process for the preparation thereof
|
GB1506816A
(en)
*
|
1975-03-31 |
1978-04-12 |
Upjohn Co |
Prostaglandins
|
DE2517771A1
(de)
|
1975-04-18 |
1976-10-28 |
Schering Ag |
Neue prostaglandin-acetylen-analoga und verfahren zu ihrer herstellung
|
JPS5328160Y2
(de)
|
1975-05-16 |
1978-07-15 |
|
|
GB1517562A
(en)
|
1975-06-13 |
1978-07-12 |
Ici Ltd |
Prostane derivatives
|
GB1520522A
(en)
|
1975-06-16 |
1978-08-09 |
Ono Pharmaceutical Co |
16-methyleneprostaglandins
|
ES449162A1
(es)
|
1975-06-23 |
1977-12-16 |
Syntex Inc |
Un procedimiento para la preparacion de un compuesto racemi-co u 8r-antimerico.
|
JPS582925B2
(ja)
|
1975-07-21 |
1983-01-19 |
カケンカガク カブシキガイシヤ |
アンテイナプロスタグランジン f2アルフア チユウシヤザイノセイホウ
|
US4005133A
(en)
|
1975-10-14 |
1977-01-25 |
The Upjohn Company |
PGF2.sub.α, L-Arginine salt
|
US4128577A
(en)
|
1975-12-29 |
1978-12-05 |
The Upjohn Company |
15-Methyl- and 16-phenoxy-PGF2 α, amides
|
US4158667A
(en)
*
|
1976-02-04 |
1979-06-19 |
The Upjohn Company |
6-Keto PGF analogs
|
US4596812A
(en)
*
|
1976-05-24 |
1986-06-24 |
The Upjohn Company |
Methods and solutions for treating male pattern alopecia
|
US4139619A
(en)
*
|
1976-05-24 |
1979-02-13 |
The Upjohn Company |
6-Amino-4-(substituted amino)-1,2-dihydro-1-hydroxy-2-iminopyrimidine, topical compositions and process for hair growth
|
US4051238A
(en)
|
1976-06-03 |
1977-09-27 |
The Upjohn Company |
Treatment of genital tract diseases of domestic animals with prostaglandins
|
US4268522A
(en)
*
|
1976-06-14 |
1981-05-19 |
Pfizer Inc. |
13,14-Dihydro-15-alkenyl- and 13,14-dihydro-15-alkynyl prostaglandins and analogs thereof
|
DE2635985A1
(de)
*
|
1976-08-06 |
1978-02-09 |
Schering Ag |
Prostansaeurederivat und verfahren zu ihrer herstellung
|
DE2737807A1
(de)
|
1976-08-27 |
1978-03-09 |
Pfizer |
C tief 1 -p-biphenylester von omega-pentanorprostaglandinen
|
DE2737808A1
(de)
|
1976-08-27 |
1978-03-16 |
Pfizer |
2-substituierte aryl-heterocyclische omega-pentanorprostaglandine
|
US4123441A
(en)
*
|
1976-09-22 |
1978-10-31 |
The Upjohn Company |
Enlarged-hetero-ring prostacyclin analogs
|
US4499293A
(en)
*
|
1976-09-22 |
1985-02-12 |
The Upjohn Company |
PGI2 Salts
|
US4089885A
(en)
*
|
1976-11-05 |
1978-05-16 |
American Home Products Corporation |
Prostaglandin derivatives
|
US4171331A
(en)
|
1978-06-05 |
1979-10-16 |
Miles Laboratories, Inc. |
1 And 2-substituted analogues of certain prostaglandins
|
US4178457A
(en)
|
1978-07-10 |
1979-12-11 |
Syntex (U.S.A.) Inc. |
(dl)-16-Phenoxy- and 16-substituted phenoxy-9-keto prostatrienoic acid derivatives and processes for the production thereof
|
US4206151A
(en)
*
|
1978-12-21 |
1980-06-03 |
American Cyanamid Company |
15-Deoxy-16-hydroxy-16-vinyl or cyclopropyl prostan-1-ols of the E, A and F series
|
US4311707A
(en)
*
|
1979-02-12 |
1982-01-19 |
American Cyanamid Company |
Process for topically producing cutaneous vasodilation for the treatment of vasospastic or ischemic conditions
|
GB2048254B
(en)
|
1979-04-02 |
1983-05-25 |
Upjohn Co |
19,20 -didehydro-19-hydroxy and 19-oxo-prostaglandin derivatives
|
JPS5829710Y2
(ja)
|
1979-05-25 |
1983-06-29 |
スガツネ工業株式会社 |
錠前
|
US4225507A
(en)
*
|
1979-07-05 |
1980-09-30 |
The Upjohn Company |
19-Hydroxy-19-methyl-PGI2 compounds
|
US4225508A
(en)
*
|
1979-07-05 |
1980-09-30 |
The Upjohn Company |
19-Hydroxy-PGI2 compounds
|
US4296504A
(en)
|
1980-07-07 |
1981-10-27 |
Lawson Daniel C |
Toilet seat lock
|
JPS6032763Y2
(ja)
|
1980-09-06 |
1985-09-30 |
日興エンジニアリング株式会社 |
液体充填装置
|
JPH0222226Y2
(de)
|
1981-02-04 |
1990-06-14 |
|
|
JPS5829710A
(ja)
|
1981-03-25 |
1983-02-22 |
ジ・アツプジヨン・カンパニ− |
Pg類による骨孔症の治療
|
US4621100A
(en)
*
|
1981-09-25 |
1986-11-04 |
The Upjohn Company |
Treatment of osteoporosis with prostaglandins
|
CH656877A5
(de)
|
1981-11-27 |
1986-07-31 |
Erba Farmitalia |
Optisch aktive oder racemische prostaglandinderivate.
|
US4599353A
(en)
|
1982-05-03 |
1986-07-08 |
The Trustees Of Columbia University In The City Of New York |
Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
|
JPS6032763A
(ja)
|
1983-07-29 |
1985-02-19 |
Nippon Iyakuhin Kogyo Kk |
新規な11−オキソプロスタン酸誘導体ならびにその利用
|
US4912235A
(en)
|
1983-12-22 |
1990-03-27 |
Syntex (U.S.A.) Inc. |
Processes and intermediates for making 16-phenoxy- and 16-substituted phenoxy-prostatrienoic acid derivatives and their stereoisomers
|
WO1986000616A1
(en)
|
1984-07-13 |
1986-01-30 |
Gail Sansone Bazzano |
Substituted pyrimidine oxides useful for hair growth promotion
|
DK346085A
(da)
|
1984-07-31 |
1986-02-01 |
Syntex Inc |
Prostatriensyrederivater
|
JPS6134778U
(ja)
|
1984-07-31 |
1986-03-03 |
株式会社明電舎 |
電気機器収納箱
|
JPS61126069A
(ja)
*
|
1984-11-21 |
1986-06-13 |
Res Dev Corp Of Japan |
プロスタグランジン誘導体
|
JPS61218510A
(ja)
|
1985-03-22 |
1986-09-29 |
Dai Ichi Seiyaku Co Ltd |
毛髪用剤
|
US5863948A
(en)
*
|
1985-06-14 |
1999-01-26 |
Massachusetts Eye And Ear Infirmary |
Increasing aqueous humor outflow
|
US4757089A
(en)
|
1985-06-14 |
1988-07-12 |
Massachusetts Eye And Ear Infirmary |
Increasing aqueous humor outflow
|
US4704386A
(en)
*
|
1985-08-29 |
1987-11-03 |
G. D. Searle & Co. |
8-chlorodibenz[b,f][1,4]oxazepine-10(11H)-carboxylic acid, 2-[(phenylsulfinyl-, and phenylsulfonyl)alkanoyl]hydrazides
|
US4883819A
(en)
|
1986-07-31 |
1989-11-28 |
The Trustees Of Columbia University In The City Of New York |
Use of A, B and C prostaglandins and derivatives thereof to treat ocular hypertension and glaucoma
|
US4889845A
(en)
*
|
1986-06-09 |
1989-12-26 |
American Cyanamid Company |
Vehicle for topical application of pharmaceuticals
|
FI872552A
(fi)
*
|
1986-06-09 |
1987-12-10 |
American Cyanamid Co |
Prostaglandinkomposition foer lokalt bruk.
|
US5041439A
(en)
|
1986-06-13 |
1991-08-20 |
The Procter & Gamble Company |
Penetrating topical pharmaceutical compositions
|
US5663203A
(en)
*
|
1986-09-11 |
1997-09-02 |
Schering Aktiengesellschaft |
Agents containing prostacyclin derivatives for topical application
|
US5500230A
(en)
*
|
1987-01-23 |
1996-03-19 |
The General Hospital Corporation |
Method for treatment of glaucoma with nitrogen containing guanylate cyclase activators
|
US5219885A
(en)
*
|
1987-02-16 |
1993-06-15 |
Froelich Juergen |
Prostaglandin E1 derivatives as pharmaceutically active agents, and pharmaceutical compositions containing these compounds, especially for transcutaneous administration
|
JPS63211231A
(ja)
|
1987-02-27 |
1988-09-02 |
Sumitomo Pharmaceut Co Ltd |
雄性不妊動物の治療剤
|
US4952581A
(en)
|
1987-04-03 |
1990-08-28 |
The Trustees Of Columbia University In The City Of New York |
Use of a prostaglandin in combination with an adrenergic blocking agent for reduction of intraocular pressure
|
US5591887A
(en)
*
|
1987-04-30 |
1997-01-07 |
R-Tech Ueno, Ltd. |
Prostaglandins of the F series
|
GB8713747D0
(en)
|
1987-06-12 |
1987-07-15 |
Unilever Plc |
Skin treatment composition
|
GB2209939B
(en)
|
1987-09-18 |
1992-01-02 |
R Tech Ueno Ltd |
The use of 13,14-dihydro-15-keto-prostaglandins as ocular hypotensive agents
|
US5166178B1
(en)
|
1987-09-18 |
1998-07-21 |
R Tech Ueno Ltd |
Ocular hypotensive agents
|
SE8703854D0
(sv)
|
1987-10-07 |
1987-10-07 |
Pharmacia Ab |
Prostaglandinderivat for behandling av glaukom eller okuler hypertension
|
AU619543B2
(en)
|
1988-05-11 |
1992-01-30 |
Sucampo Ag |
Use of 15-ketoprostaglandin e or f compounds for uterine contraction
|
JPH0222226A
(ja)
|
1988-07-12 |
1990-01-25 |
Ono Pharmaceut Co Ltd |
Pgd類似化合物を有効成分として含有する骨疾患治療剤
|
US5296504A
(en)
*
|
1988-09-06 |
1994-03-22 |
Kabi Pharmacia |
Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
|
US6187813B1
(en)
|
1990-04-10 |
2001-02-13 |
Pharmacia & Upjohn Aktiebolag |
Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
|
DE03014533T1
(de)
|
1988-09-06 |
2004-07-15 |
Pharmacia Ab |
Prostaglandinderivative zur Behandlung von Glaukom oder okuläre Hypertension
|
US5321128A
(en)
*
|
1988-09-06 |
1994-06-14 |
Kabi Pharmacia Ab |
Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
|
US5194429A
(en)
*
|
1988-10-01 |
1993-03-16 |
K.K. Ueno Seiyaku Oyo Kenkyujo |
Ocular hypotensive agents
|
FR2647675B1
(fr)
|
1989-06-05 |
1994-05-20 |
Sanofi |
Utilisation d'un derive de la statine dans le traitement des affections oculaires
|
US4968812A
(en)
|
1989-06-23 |
1990-11-06 |
Shell Oil Company |
Spirolactonelactams
|
JPH0737390B2
(ja)
|
1989-08-29 |
1995-04-26 |
久光製薬株式会社 |
軟膏組成物
|
JPH0737389B2
(ja)
|
1989-08-29 |
1995-04-26 |
久光製薬株式会社 |
プロスタグランジンe1含有の軟膏剤
|
CA1339132C
(en)
|
1989-09-12 |
1997-07-29 |
Johan W. Stjernschantz |
Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
|
CA2030345C
(en)
*
|
1989-11-22 |
1998-12-08 |
Ryuji Ueno |
Use of 15-keto-prostaglandin compound for improvement of encephalic function
|
JPH0627942Y2
(ja)
|
1989-12-14 |
1994-07-27 |
松下電器産業株式会社 |
ヒューズホルダー付コンデンサー
|
JPH0720909Y2
(ja)
|
1989-12-14 |
1995-05-15 |
松下電器産業株式会社 |
コンデンサー
|
TW224942B
(de)
*
|
1990-04-04 |
1994-06-11 |
Adka Ueno Kk |
|
US5302617A
(en)
*
|
1990-04-27 |
1994-04-12 |
Kabushikikaisha Ueno Seiyaku Oyo Kenkyuio |
Biochemical treatment with 15-dehydroxy-16-oxoprostaglandin compounds
|
US5063057A
(en)
*
|
1990-09-26 |
1991-11-05 |
Elizabeth Arden Co., Division Of Conopco, Inc. |
Cosmetic capsules
|
DE4024347A1
(de)
|
1990-07-27 |
1992-01-30 |
Schering Ag |
Cyclopentanderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
|
JPH04300833A
(ja)
|
1991-03-29 |
1992-10-23 |
Green Cross Corp:The |
プロスタグランジンe1 含有脂肪乳剤充填噴霧剤
|
US5378840A
(en)
*
|
1992-04-16 |
1995-01-03 |
G. D. Searle & Co. |
Substituted dibenzoxazepine compounds
|
US5312832A
(en)
*
|
1991-05-17 |
1994-05-17 |
Allergan, Inc. |
Ocular hypotensive 2-decarboxyl-2-acylthioalkyl prostaglandin derivatives
|
US5288754A
(en)
*
|
1992-02-04 |
1994-02-22 |
Allergan, Inc. |
Polar C-1 esters of prostaglandins
|
US5641494A
(en)
*
|
1992-03-20 |
1997-06-24 |
Janssen Pharmaceutica N.V. |
Agent for regulating the greasiness of the skin
|
US5578643A
(en)
*
|
1992-05-20 |
1996-11-26 |
Loyola University Of Chicago |
Protective prostaglandins for use in conjunction with chemotherapeutic agents
|
US5422371A
(en)
*
|
1992-05-27 |
1995-06-06 |
Arch Development Corp. |
Methods and compositions for inhibiting 5α-reductase activity
|
JP3102141B2
(ja)
|
1992-05-29 |
2000-10-23 |
東レ株式会社 |
養毛育毛剤
|
US5817694A
(en)
*
|
1992-06-08 |
1998-10-06 |
New Pharma International Corp. |
16-methyl-11,16-dihydroxy-9-oxoprost-2,13-dien-1-oic acid and derivatives
|
US5409911A
(en)
*
|
1992-09-11 |
1995-04-25 |
Merck & Co., Inc. |
Prostaglandin analog for treating osteoporosis
|
US5834498A
(en)
*
|
1992-09-21 |
1998-11-10 |
Allergan |
Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
|
US5352708A
(en)
*
|
1992-09-21 |
1994-10-04 |
Allergan, Inc. |
Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
|
US5688819A
(en)
|
1992-09-21 |
1997-11-18 |
Allergan |
Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
|
US5972991A
(en)
*
|
1992-09-21 |
1999-10-26 |
Allergan |
Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
|
ES2105333T3
(es)
|
1992-10-13 |
1997-10-16 |
Alcon Lab Inc |
Combinaciones de prostaglandinas y derivados de clonidina para el tratamiento del glaucoma.
|
US5332730A
(en)
|
1992-10-16 |
1994-07-26 |
Allergan, Inc. |
Azido derivatives of cyclopentane heptanoic or heptenoic acid
|
US5340813A
(en)
*
|
1992-11-09 |
1994-08-23 |
Cell Therapeutics, Inc. |
Substituted aminoalkyl xanthine compounds
|
DE4238830A1
(de)
*
|
1992-11-17 |
1994-05-19 |
Anton Felder |
Verfahren zum hydraulischen Verzweigen einer offenen Strömung sowie hydraulisch arbeitende Kanalverzweigung
|
US5670506A
(en)
*
|
1993-04-05 |
1997-09-23 |
Cell Therapeutics, Inc. |
Halogen, isothiocyanate or azide substituted xanthines
|
US5395932A
(en)
*
|
1993-04-30 |
1995-03-07 |
G. D. Searle & Co. |
2,3-,4-,5-,6-,7-,8-,9- and/or 10-substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
|
US5985597A
(en)
*
|
1993-05-26 |
1999-11-16 |
Merck Frosst Canada, Inc. |
DNA encoding prostaglandin receptor EP1
|
US5869281A
(en)
*
|
1993-06-25 |
1999-02-09 |
Merck Frosst Canada Inc. |
DNA encoding prostaglandin receptor FP
|
ES2122291T3
(es)
|
1993-06-25 |
1998-12-16 |
Merck Frosst Canada Inc |
Receptor ep3 de la prostaglandina y adn que lo codifica.
|
US5510383A
(en)
*
|
1993-08-03 |
1996-04-23 |
Alcon Laboratories, Inc. |
Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension
|
US5605814A
(en)
*
|
1993-08-31 |
1997-02-25 |
Merck Frosst Canada Inc. |
DNA encoding human prostaglandin receptor EP2
|
US5516652A
(en)
*
|
1993-10-06 |
1996-05-14 |
Merck Frosst Canada Inc. |
DNA encoding prostaglandin receptor IP
|
FR2711060B1
(fr)
|
1993-10-13 |
1995-11-17 |
Oreal |
Procédé pour modifier la pousse des poils et/ou des cheveux et compositions utilisables à cet effet.
|
SE9303444D0
(sv)
|
1993-10-20 |
1993-10-20 |
Kabi Pharmacia Ab |
New use of prostaglandins
|
WO1995011033A1
(en)
|
1993-10-22 |
1995-04-27 |
Commonwealth Scientific And Industrial Research Organisation |
Polyoxometallates in the treatment of flavivirus infections
|
SE9303627D0
(sv)
*
|
1993-11-03 |
1993-11-03 |
Kabi Pharmacia Ab |
Method and means for prevention of cataract
|
US5431881A
(en)
|
1993-12-10 |
1995-07-11 |
Palacios; Henry J. |
Treatment of hair loss and dermatological problems
|
AU686286B2
(en)
*
|
1993-12-20 |
1998-02-05 |
Fujisawa Pharmaceutical Co., Ltd. |
4,5-diaryloxazole derivatives
|
US6124344A
(en)
|
1993-12-28 |
2000-09-26 |
Allergan Sales, Inc. |
Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
|
US5545665A
(en)
|
1993-12-28 |
1996-08-13 |
Allergan |
Cyclopentane(ene) heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents
|
US5458883A
(en)
|
1994-01-12 |
1995-10-17 |
Duke University |
Method of treating disorders of the eye
|
US5462968A
(en)
|
1994-01-19 |
1995-10-31 |
Allergan, Inc. |
EP2 -receptor agonists as agents for lowering intraocular pressure
|
SE9403158D0
(sv)
*
|
1994-09-21 |
1994-09-21 |
Pharmacia Ab |
New use of prostaglandins
|
US5698733A
(en)
|
1994-09-30 |
1997-12-16 |
Alcon Laboratories, Inc. |
Use of 9-deoxy prostaglandin derivatives to treat glaucoma
|
US5885974A
(en)
*
|
1994-12-06 |
1999-03-23 |
Michael M. Danielov |
Therapeutic methods utilizing naturally derived bio-active complexes and delivery systems therefor
|
WO1996020925A1
(fr)
*
|
1995-01-06 |
1996-07-11 |
Toray Industries, Inc. |
Derive heterocyclique benzocondense et son utilisation
|
JP3064015B2
(ja)
*
|
1995-01-26 |
2000-07-12 |
メルク フロスト カナダ アンド カンパニー |
プロスタグランジンレセプターdp
|
US5885766A
(en)
*
|
1995-02-17 |
1999-03-23 |
Societe L'oreal S.A. |
Method of screening of substances for their effect on the expression of mediators of inflammation in a hair follicle
|
FR2730811B1
(fr)
|
1995-02-17 |
1997-03-21 |
Oreal |
Procede pour diagnostiquer et/ou suivre l'evolution d'un desordre capillaire et/ou mesurer l'efficacite d'un traitement applique pour combattre un desordre capillaire
|
JPH11505802A
(ja)
|
1995-05-18 |
1999-05-25 |
アラーガン |
高眼圧処置剤としてのシクロペンタンヘプタン(エン)酸,2−ヘテロアリールアルケニル誘導体
|
WO1998021180A1
(en)
|
1995-06-07 |
1998-05-22 |
Alcon Laboratories, Inc. |
Conformationally rigid aryl- or heteroaryl prostaglandins for use in glaucoma therapy
|
WO1997001534A1
(fr)
*
|
1995-06-26 |
1997-01-16 |
Teijin Limited |
Prostaglandines et procede pour la production de celles-ci
|
TW401408B
(en)
|
1995-07-21 |
2000-08-11 |
Fujisawa Pharmaceutical Co |
Heterocyclic compounds having prostaglandin I2 agonism
|
HUP9601442A3
(en)
*
|
1995-07-25 |
1999-03-29 |
Panacea Biotec Ltd |
Nes antinflammatory and analgetic pharmaceutical compositions, containing nimesulid for transdermal use, and process for producing them
|
US5661178A
(en)
|
1995-09-01 |
1997-08-26 |
Allergan |
Method for effecting vasodilation with (1,5-inter)aryl prostaglandin derivatives
|
US6251436B1
(en)
|
1995-09-29 |
2001-06-26 |
L.A.M. Pharmaceutical Corporation |
Drug preparations for treating sexual dysfunction
|
WO1997015319A1
(en)
|
1995-10-23 |
1997-05-01 |
Queen's University At Kingston |
Method and pharmaceutical composition for chondrostimulation with a prostaglandin (e.g. misoprostol) and tgf-beta, optionally in combination with igf-1
|
US6441047B2
(en)
|
1995-11-17 |
2002-08-27 |
Alcon Manufacturing Ltd.. |
Combination therapy for treating glaucoma
|
US5866602A
(en)
|
1995-12-22 |
1999-02-02 |
Alcon Laboratories, Inc. |
Keto-substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives
|
WO1997023225A1
(en)
|
1995-12-22 |
1997-07-03 |
Alcon Laboratories, Inc. |
Combinations of dp and fp type prostaglandins for lowering iop
|
WO1997023223A1
(en)
*
|
1995-12-22 |
1997-07-03 |
Alcon Laboratories, Inc. |
Substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives
|
US5814660A
(en)
|
1995-12-22 |
1998-09-29 |
Alcon Laboratories, Inc. |
9-oxa prostaglandin analogs as ocular hypotensives
|
WO1997023226A1
(en)
|
1995-12-22 |
1997-07-03 |
Alcon Laboratories, Inc. |
Combinations of prostaglandins and miotics for lowering intraocular pressure
|
AUPN814496A0
(en)
|
1996-02-19 |
1996-03-14 |
Monash University |
Dermal penetration enhancer
|
US5703108A
(en)
*
|
1996-02-28 |
1997-12-30 |
Pfizer Inc. |
Bone deposition by certain prostaglandin agonists
|
US5741810A
(en)
|
1996-02-29 |
1998-04-21 |
Allergan |
Cyclopentane heptan(ene)oic acid, 2- heteroarylalkenyl derivatives as therapeutic agents
|
US5658897A
(en)
*
|
1996-04-08 |
1997-08-19 |
Allergan |
Cyclopentane(ene) heptanoic or cyclopentane(ene) heptenoic acid, 2-hydrocarbyl phosphinyloxyalkyl or phosphonamidoalkyl as therapeutic agents
|
US5990168A
(en)
|
1996-04-18 |
1999-11-23 |
Alberta Cancer Board |
Methods and compositions for the treatment of ataxia telangiectasia
|
JP3049593B2
(ja)
|
1996-05-01 |
2000-06-05 |
株式会社ビメーク |
育毛・養毛剤
|
ATE222237T1
(de)
|
1996-06-10 |
2002-08-15 |
Sucampo Ag |
Endothelin-antagonisten
|
WO1998000100A1
(en)
|
1996-07-03 |
1998-01-08 |
The Board Of Regents Of The University Of Oklahoma |
Enhancement of skin pigmentation by prostaglandins
|
US5792851A
(en)
*
|
1996-09-03 |
1998-08-11 |
Albert Einstin College Of Medicine Of Yeshiva University, A Division Of Yeshiva University |
Human prostaglandin transporter
|
JP4004109B2
(ja)
|
1996-09-17 |
2007-11-07 |
参天製薬株式会社 |
含フッ素プロスタグランジン誘導体および医薬
|
WO1998012175A1
(fr)
|
1996-09-17 |
1998-03-26 |
Asahi Glass Company Ltd. |
Derives de prostaglandine fluores et medicaments
|
US5827508A
(en)
|
1996-09-27 |
1998-10-27 |
The Procter & Gamble Company |
Stable photoprotective compositions
|
JP2001504100A
(ja)
|
1996-11-01 |
2001-03-27 |
アルコン・ラボラトリーズ・インコーポレーテッド |
緑内障を治療するための炭酸脱水素酵素阻害剤とプロスタグランジンとの組合せの使用
|
WO1998020880A2
(en)
|
1996-11-12 |
1998-05-22 |
Alcon Laboratories, Inc. |
11-halo prostaglandins for the treatment of glaucoma or ocular hypertension
|
AU5439398A
(en)
|
1996-11-12 |
1998-06-03 |
Alcon Laboratories, Inc. |
Cis-delta4 analogs of prostaglandins as ocular hypotensives
|
DE69705421T2
(de)
|
1996-11-12 |
2002-05-16 |
Alcon Laboratories, Inc. |
15-fluoro-prostaglandine als augendrucksenkende mittel
|
AU5258698A
(en)
|
1996-11-12 |
1998-06-03 |
Alcon Laboratories, Inc. |
15-ketal prostaglandins for the treatment of glaucoma or ocular hypertension
|
TW523506B
(en)
|
1996-12-18 |
2003-03-11 |
Ono Pharmaceutical Co |
Sulfonamide or carbamide derivatives and drugs containing the same as active ingredients
|
IL130333A0
(en)
|
1996-12-20 |
2000-06-01 |
Pfizer |
Prevention and treatment of skeletal disorder with EP2 receptor subtype selective prostaglandin E2 agonists
|
UA59384C2
(uk)
|
1996-12-20 |
2003-09-15 |
Пфайзер, Інк. |
Похідні сульфонамідів та амідів як агоністи простагландину, фармацевтична композиція та способи лікування на їх основі
|
JPH10265454A
(ja)
*
|
1997-01-27 |
1998-10-06 |
Ono Pharmaceut Co Ltd |
3,7−ジチアプロスタン酸誘導体、それらの製造方法およびそれらを有効成分として含有する薬剤
|
WO1998033497A1
(en)
|
1997-02-04 |
1998-08-06 |
Johnstone Murray A |
Method of enhancing hair growth
|
NO317155B1
(no)
|
1997-02-04 |
2004-08-30 |
Ono Pharmaceutical Co |
<omega>-cykloalkyl-prostagladin-E<N>2</N>-derivater
|
ES2196527T3
(es)
|
1997-02-10 |
2003-12-16 |
Ono Pharmaceutical Co |
Derivados de 11,15-o-dialquilprostaglandina e, su procedimiento de produccion y medicamentos que incluyen estos como principio activo.
|
AU6117398A
(en)
|
1997-02-27 |
1998-09-18 |
Toray Industries, Inc. |
Drugs for ameliorating pulmonary circulation
|
EP0968183A2
(de)
|
1997-03-07 |
2000-01-05 |
Alcon Laboratories, Inc. |
13-thia-prostaglandine zur verwendung in der glaukomtherapie
|
US6030959A
(en)
*
|
1997-04-04 |
2000-02-29 |
Monsanto Company |
Gastro-specific prodrugs
|
JP3217293B2
(ja)
*
|
1997-04-17 |
2001-10-09 |
株式会社アールテック・ウエノ |
発毛・育毛剤
|
IT1291633B1
(it)
|
1997-04-22 |
1999-01-11 |
Pharmaconsult S A S |
Uso dell'alfa-metil-p-tirosina per inibire la produzione di melanina nei melanociti dell'iride
|
WO1998050024A1
(en)
|
1997-05-09 |
1998-11-12 |
The Mount Sinai School Of Medicine Of The City University Of New York |
8-iso-prostaglandins for glaucoma therapy
|
WO1998053809A1
(en)
|
1997-05-30 |
1998-12-03 |
Merck & Co., Inc. |
Ophthalmic compositions for treating ocular hypertension
|
US6531485B2
(en)
|
1997-06-23 |
2003-03-11 |
Pfizer Inc. |
Prostaglandin agonists
|
SE9702706D0
(sv)
|
1997-07-11 |
1997-07-11 |
Pharmacia & Upjohn Ab |
Prostaglandin derivatives devoid of side-effects for the treatment of glaucoma
|
DE69838645D1
(de)
|
1997-09-08 |
2007-12-13 |
Abraham Pinter |
Epitope der gp120 v1/v" domäne von hiv-1 geeignet zur herstellung neutralisierender antikörper
|
WO1999012553A1
(en)
|
1997-09-08 |
1999-03-18 |
Idec Pharmaceuticals Corporation |
Methods for producing human antibodies in scid mice using dendritic cells
|
BR9811775A
(pt)
|
1997-09-09 |
2000-08-29 |
Procter & Gamble |
Método de aumento de volume ósseo
|
ID23971A
(id)
|
1997-09-09 |
2000-06-14 |
Procter & Gamble |
Prostaglandin tetrahidro tersubstitusic c<16>-c<20> aromatik yang berguna sebagai agonis fp
|
AUPO907697A0
(en)
|
1997-09-09 |
1997-10-02 |
Day, Robert Edward |
Chemical supplementation of bone
|
JP2001515864A
(ja)
|
1997-09-09 |
2001-09-25 |
ザ プロクター アンド ギャンブル カンパニー |
非天然fp選択的作用薬を使用した骨体積増加方法
|
JP4619531B2
(ja)
|
1997-09-09 |
2011-01-26 |
デューク ユニバーシティ |
Fpアゴニストとして有用な、芳香族のあるc16〜c20が置換されたテトラヒドロプロスタグランジン類
|
PL195703B1
(pl)
|
1997-09-09 |
2007-10-31 |
Hoffmann La Roche |
Zastosowanie polipeptydowego analogu peptydu pokrewnego hormonowi przytarczyc
|
TR200000672T2
(tr)
|
1997-09-09 |
2000-07-21 |
The Procter & Gamble Company |
Epoksit aramaddeleri hazırlamak için bir işlem.
|
ATE363914T1
(de)
|
1997-09-09 |
2007-06-15 |
Curis Inc |
Synergistische wirkung des ob/bmp morphogens und gdnf/ngf neurotropher faktoren
|
CA2304108A1
(en)
|
1997-09-09 |
1999-03-18 |
The Regents Of The University Of California |
Inhibition of apoptotis using prosaposin receptor agonists
|
WO1999012899A1
(en)
|
1997-09-09 |
1999-03-18 |
The Procter & Gamble Company |
A process for making prostaglandin f analogs
|
AU741014B2
(en)
|
1997-09-09 |
2001-11-22 |
Duke University |
Aromatic C16-C20-substituted tetrahydro prostaglandins useful as FP agonists
|
WO1999012558A1
(en)
|
1997-09-10 |
1999-03-18 |
Allegheny University Of The Health Sciences |
Inhibitors of collagen assembly
|
NZ502861A
(en)
|
1997-09-10 |
2001-03-30 |
Merck & Co Inc |
Method of treating livestock bacterial respiratory or enteric infections using 9a-azalides
|
JP2001515869A
(ja)
|
1997-09-11 |
2001-09-25 |
アメリカ合衆国 |
粘膜の細胞障害性tリンパ球応答
|
WO1999012555A1
(en)
|
1997-09-11 |
1999-03-18 |
Purdue Research Foundation |
Galactosidase modified submucosal tissue
|
WO1999012557A1
(en)
|
1997-09-12 |
1999-03-18 |
Smithkline Beecham Corporation |
Novel prokaryotic polynucleotides, polypeptides and their uses
|
WO1999013881A1
(fr)
|
1997-09-17 |
1999-03-25 |
Toray Industries, Inc. |
Agent de maturation cervical
|
WO1999015502A1
(fr)
|
1997-09-19 |
1999-04-01 |
Shionogi & Co., Ltd. |
Composes ayant un squelette [2.2.1]bicyclo
|
UA67754C2
(uk)
|
1997-10-10 |
2004-07-15 |
Пфайзер, Інк. |
Агоністи простагландину, фармацевтична композиція на їх основі (варіанти), спосіб нарощення та збереження кісткової маси у хребетних та спосіб лікування (варіанти)
|
US6124314A
(en)
|
1997-10-10 |
2000-09-26 |
Pfizer Inc. |
Osteoporosis compounds
|
AU740758B2
(en)
|
1997-10-28 |
2001-11-15 |
Vivus, Inc. |
Treatment of female sexual dysfunction
|
AUPP010397A0
(en)
|
1997-10-30 |
1997-11-20 |
Vaisman, Jakov |
Method and composition for treatment of sexual dysfunction
|
DE69822665T2
(de)
|
1997-11-14 |
2005-02-17 |
United Therapeutics Corp. |
Verwendung von 9-desoxy-2',9-alpha-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylen)-13,14-dihydroprostaglandin-f1 zur behandlung von peripheren vaskulären erkrankungen
|
US5877211A
(en)
*
|
1997-11-21 |
1999-03-02 |
Allergan |
EP2 receptor agonists as neuroprotective agents for the eye
|
EP1059926A2
(de)
|
1997-12-18 |
2000-12-20 |
SCOTT, Nathan Earl |
Kombination, bestehend aus den prostaglandinen e2/f2-alpha, zur behandlung der impotenz und zur erhöhung der sexuelllen erregbarkeit
|
US6099870A
(en)
|
1997-12-18 |
2000-08-08 |
Johnson & Johnson Consumer Companies, Inc. |
Methods for improving the health of hair and scalp
|
WO1999032641A1
(en)
|
1997-12-22 |
1999-07-01 |
Unilever N.V. |
A process for site-directed integration of multiple copies of a gene in a mould
|
US5955575A
(en)
|
1997-12-22 |
1999-09-21 |
Hopital Sainte-Justine |
Antagonists of G-protein-coupled receptor
|
WO1999032441A1
(en)
|
1997-12-22 |
1999-07-01 |
Alcon Laboratories, Inc. |
13-oxa prostaglandins for the treatment of glaucoma and ocular hypertension
|
US6262293B1
(en)
|
1997-12-25 |
2001-07-17 |
Ono Pharmaceutical Co., Ltd. |
ω-Cycloalkly-prostaglandin e2 derivatives
|
GB2330307A
(en)
|
1998-02-07 |
1999-04-21 |
Glaxo Group Ltd |
EP4 Receptor antagonists as bone resorption inhibitors
|
EP1071648A2
(de)
|
1998-03-13 |
2001-01-31 |
Merck Frosst Canada & Co. |
CARBONSÄUREN UND ACYLSULFONAMIDE, SOLCHE VERBINDUNGEN ENTHALTENDE Gemenge UND BEHANDLUNGSVERFAHREN
|
NZ506855A
(en)
|
1998-03-31 |
2003-02-28 |
Procter & Gamble |
C11 Oxymyl and hydroxylamino prostaglandins useful as FP agonists
|
TR200002808T2
(tr)
*
|
1998-03-31 |
2001-01-22 |
The Procter & Gamble Company |
İlaç olarak yararlı C11 oksimil ve hidroksilamino prostaglandinleri
|
US6444840B1
(en)
|
1998-03-31 |
2002-09-03 |
The Procter & Gamble Co. |
C11 oxymyl and hydroxylamino prostaglandins useful as FP agonists
|
WO1999061419A1
(fr)
|
1998-05-25 |
1999-12-02 |
Taisho Pharmaceutical Co., Ltd. |
Derive de prostaglandine
|
US6458549B2
(en)
|
1998-06-11 |
2002-10-01 |
Winthrop-University Hospital |
Methods of diagnosing renal salt wasting syndrome and Alzheimer's disease and methods of treating the same
|
US5942545A
(en)
|
1998-06-15 |
1999-08-24 |
Macrochem Corporation |
Composition and method for treating penile erectile dysfunction
|
US6187818B1
(en)
|
1998-06-17 |
2001-02-13 |
Pharmacia & Upjohn Company |
Prostaglandins formulation and process
|
WO2000002450A1
(en)
|
1998-07-08 |
2000-01-20 |
Fibrogen, Inc. |
Method for treatment of fibrosis related diseases by the administration of prostacyclin derivatives
|
PT1011728E
(pt)
|
1998-07-14 |
2005-03-31 |
Alcon Mfg Ltd |
Recipientes de polipropileno para produtos de prostaglandina
|
TWI249520B
(en)
|
1998-07-15 |
2006-02-21 |
Ono Pharmaceutical Co |
5-Thia-omega-substituted phenyl prostaglandin E derivatives, method for producing the same and medicines containing the same as the active ingredient
|
EP1100491A1
(de)
|
1998-07-21 |
2001-05-23 |
Merck & Co., Inc. |
Ophthalmologische zusammenstellungen zur behandlung von ocularer hypertension
|
EP1109546A1
(de)
|
1998-07-21 |
2001-06-27 |
Merck & Co., Inc. |
Ophthalmika zur behandlung der okularen hypertension
|
US6284234B1
(en)
*
|
1998-08-04 |
2001-09-04 |
Johnson & Johnson Consumer Companies, Inc. |
Topical delivery systems for active agents
|
AU5196699A
(en)
|
1998-08-12 |
2000-03-06 |
Kazusa Dna Research Institute Foundation |
Novel gene and protein pgth encoded thereby
|
WO2000015608A1
(en)
|
1998-09-14 |
2000-03-23 |
Ono Pharmaceutical Co., Ltd. |
φ-SUBSTITUTED PHENYL-PROSTAGLANDIN E DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT
|
AUPP608898A0
(en)
|
1998-09-23 |
1998-10-15 |
Fujisawa Pharmaceutical Co., Ltd. |
New use of prostaglandin E2 antagonists
|
US6121253A
(en)
|
1998-11-20 |
2000-09-19 |
Merck Frosst Canada & Co. |
Prostaglandin conjugates for treating or preventing bone disease
|
ATE272609T1
(de)
|
1999-03-01 |
2004-08-15 |
Pfizer Prod Inc |
Oxamsäure und deren derivate als liganden der thyroid-rezeptoren
|
BR0008778A
(pt)
|
1999-03-05 |
2001-12-18 |
Procter & Gamble |
Análogos de prostaglandinas seletivos para fpc16 insaturados
|
AU766163B2
(en)
|
1999-03-05 |
2003-10-09 |
Duke University |
C16 unsaturated fp-selective prostaglandins analogs
|
EP1169061A1
(de)
|
1999-03-12 |
2002-01-09 |
Alcon Laboratories, Inc. |
Kombinationstherapie zur behandlung von glaukom
|
US6894175B1
(en)
*
|
1999-08-04 |
2005-05-17 |
The Procter & Gamble Company |
2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
|
AU776375B2
(en)
*
|
1999-08-04 |
2004-09-09 |
Duke University |
Novel 2-decarboxy-2-phosphinico prostaglandin F analogs
|
US6548535B2
(en)
|
2000-01-18 |
2003-04-15 |
Merck & Co., Inc. |
Method for treating ocular hypertension
|
IL143477A
(en)
|
2001-05-31 |
2009-07-20 |
Finetech Pharmaceutical Ltd |
Process for the preparation of 17-phenyl-18,19,20-trinor-pgf2?? and its derivatives
|
US20020013294A1
(en)
*
|
2000-03-31 |
2002-01-31 |
Delong Mitchell Anthony |
Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
|
US20020172693A1
(en)
|
2000-03-31 |
2002-11-21 |
Delong Michell Anthony |
Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
|
EP1186287A1
(de)
*
|
2000-03-31 |
2002-03-13 |
Toray Industries, Inc. |
Haarwachstums- oder haarbildungsregulatoren
|
US20020037914A1
(en)
*
|
2000-03-31 |
2002-03-28 |
Delong Mitchell Anthony |
Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
|
US20020146439A1
(en)
|
2000-03-31 |
2002-10-10 |
Delong Mitchell Anthony |
Compositions and methods for treating hair loss using oximyl and hydroxylamino prostaglandins
|
FR2812191B1
(fr)
|
2000-07-28 |
2003-10-17 |
Oreal |
Utilisation d'agonistes du recepteur des prostaglandines e2 (ep-3) pour attenuer, diminuer ou stopper la pousse des cheveux et des poils dans des preparations cosmetiques
|
FR2812193B1
(fr)
|
2000-07-28 |
2003-10-24 |
Oreal |
Utilisation d'antagoniste des recepteurs des prostaglandines ep-2 et/ou ep-4 pour attenuer, diminuer ou stopper la pousse des cheveux et des poils dans des preparations cosmetiques
|
FR2812190B1
(fr)
*
|
2000-07-28 |
2003-01-31 |
Oreal |
Utilisation d'agonistes non prostanoiques des recepteurs des prostaglandines ep-2 et/ou ep-4 comme agent cosmetique permettant d'attenuer, de diminuer ou d'arreter la chute des cheveux et des poils
|
TWI288000B
(en)
|
2001-02-22 |
2007-10-11 |
Rtp Pharma Inc |
Fibrate-statin combinations with reduced fed-fasted effects
|
EP1298223A3
(de)
|
2001-09-28 |
2003-07-23 |
Pfizer Products Inc. |
Methoden die mit der A-C Wiederholungs-Z-Sequenz stromaufwärts des Aldosereduktasegens in Zusammenhang stehen
|
SE0104334D0
(sv)
|
2001-12-19 |
2001-12-19 |
Astrazeneca Ab |
Therapeutic agents
|
US20040082013A1
(en)
|
2002-01-24 |
2004-04-29 |
Regan John W |
Methods for screening for substances which inhibit fp prostanoid receptor interaction with a compound having pgf2alpha activity and methods of treating cancer
|
US7351404B2
(en)
|
2002-02-04 |
2008-04-01 |
Allergan, Inc. |
Method of enhancing hair growth
|
ES2268327T3
(es)
|
2002-03-18 |
2007-03-16 |
Pfizer Products Inc. |
Uso de un selectivo de un receptor de ep4 para el tratamiento de enfermedades.
|
US7186707B2
(en)
|
2002-04-01 |
2007-03-06 |
University Of Florida |
Prodrugs for use as ophthalmic agents
|
GB0208785D0
(en)
|
2002-04-17 |
2002-05-29 |
Medical Res Council |
Treatment methtods
|
US7320967B2
(en)
*
|
2002-04-23 |
2008-01-22 |
L'oreal |
Cosmetic composition, method of cosmetic treatment and preparation of a composition for promoting the growth and/or preventing or delaying the loss of hair
|
US6573294B1
(en)
|
2002-05-14 |
2003-06-03 |
Allergan, Inc. |
8-azaprostaglandin analogs as agents for lowering intraocular pressure
|
US7521530B2
(en)
|
2002-06-11 |
2009-04-21 |
Universite De Montreal |
Peptides and peptidomimetics useful for inhibiting the activity of prostaglandin F2α receptor
|
US20030199590A1
(en)
|
2002-07-25 |
2003-10-23 |
Cagle Gerald D |
Prostaglandin analogues for promotion of hair growth
|
US7589233B2
(en)
|
2003-07-29 |
2009-09-15 |
Signature R&D Holdings, Llc |
L-Threonine derivatives of high therapeutic index
|
US7045634B2
(en)
|
2003-09-05 |
2006-05-16 |
Allergan, Inc. |
Prostamide receptor antagonists
|
US20050058614A1
(en)
*
|
2003-09-15 |
2005-03-17 |
Allergan, Inc. |
Methods for the treatment of gray hair using cyclopentane(ene) heptan(en)oic acid amides
|
US7070768B2
(en)
|
2003-09-25 |
2006-07-04 |
Allergan, Inc. |
Method for imparting artificial tan to human skin
|
US20050112075A1
(en)
|
2003-11-25 |
2005-05-26 |
Hwang Cheng S. |
Reduction of hair growth
|
WO2005053683A1
(en)
|
2003-11-26 |
2005-06-16 |
Duke University |
A method of preventing or treating glaucoma
|
US7288029B1
(en)
|
2005-01-19 |
2007-10-30 |
Gkn Driveline North America, Inc. |
Propshaft with crash-worthiness
|
JP2008517941A
(ja)
|
2004-10-21 |
2008-05-29 |
デューク・ユニバーシティー |
眼科用薬剤
|
GB0506759D0
(en)
|
2005-04-02 |
2005-05-11 |
Medical Res Council |
Combination treatment methods
|
WO2007123818A2
(en)
|
2006-04-18 |
2007-11-01 |
Nitromed, Inc. |
Organic nitric oxide enhancing salts of prostaglandins, compositions and methods of use
|
US20070254920A1
(en)
|
2006-04-26 |
2007-11-01 |
Aerie Pharmaceuticals, Inc. |
Prodrug derivatives of acids using alcohols with homotopic hydroxy groups and methods for their preparation and use
|
US7868032B2
(en)
|
2006-10-18 |
2011-01-11 |
Allergan, Inc. |
Prostamide receptor antagonists
|
US20090018204A1
(en)
|
2007-07-13 |
2009-01-15 |
Brinkenhoff Michael C |
Composition and method for enhancing hair growth
|
JP2012507552A
(ja)
|
2008-10-29 |
2012-03-29 |
アエリエ・ファーマシューティカルズ・インコーポレーテッド |
プロスタグラジンのアミノ酸塩
|
US8623918B2
(en)
|
2008-10-29 |
2014-01-07 |
Novaer Holdings, Inc. |
Amino acid salts of prostaglandins
|
US8722739B2
(en)
*
|
2008-10-29 |
2014-05-13 |
Novaer Holdings, Inc. |
Amino acid salts of prostaglandins
|
WO2010108012A1
(en)
|
2009-03-18 |
2010-09-23 |
Duke University |
Compositions and methods for promoting nasal patency and treating neurogenic bladder using prostaglandins
|